Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory <scp>FLT3</scp> ‐ <scp>ITD</scp> –Positive <scp>AML</scp>

Yuichiro Semba, Toshihiro Miyamoto, Senji Kasahara, Yoshikane Kikushige, Takahiro Maeda, Goichi Yoshimoto, Shuichi Ota, Akio Saito, Yuho Najima, Hiroki Hosoi, Daigo Niiya, Koji Kato, Koji Nagafuji, Takashi Akasaka, Tomohiko Kamimura, Atsushi Takita, Maiko Narahara, Tadashi Toki, Koichi Iwanaga, Koji Yonemoto, Mine Harada, Koichi Akashi

Open source

DOI: 10.1111/cas.70485
Published: 2026-08-12
Container: Cancer Science
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/cas.70485,
  title = {Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory
                    <scp>FLT3</scp>
                    ‐
                    <scp>ITD</scp>
                    –Positive
                    <scp>AML</scp>},
  author = {Yuichiro Semba and Toshihiro Miyamoto and Senji Kasahara and Yoshikane Kikushige and Takahiro Maeda and Goichi Yoshimoto and Shuichi Ota and Akio Saito and Yuho Najima and Hiroki Hosoi and Daigo Niiya and Koji Kato and Koji Nagafuji and Takashi Akasaka and Tomohiko Kamimura and Atsushi Takita and Maiko Narahara and Tadashi Toki and Koichi Iwanaga and Koji Yonemoto and Mine Harada and Koichi Akashi},
  year = {2026},
  journal = {Cancer Science},
  doi = {10.1111/cas.70485},
  url = {https://doi.org/10.1111/cas.70485}
}

RIS

TY  - JOUR
TI  - Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory
                    <scp>FLT3</scp>
                    ‐
                    <scp>ITD</scp>
                    –Positive
                    <scp>AML</scp>
AU  - Yuichiro Semba
AU  - Toshihiro Miyamoto
AU  - Senji Kasahara
AU  - Yoshikane Kikushige
AU  - Takahiro Maeda
AU  - Goichi Yoshimoto
AU  - Shuichi Ota
AU  - Akio Saito
AU  - Yuho Najima
AU  - Hiroki Hosoi
AU  - Daigo Niiya
AU  - Koji Kato
AU  - Koji Nagafuji
AU  - Takashi Akasaka
AU  - Tomohiko Kamimura
AU  - Atsushi Takita
AU  - Maiko Narahara
AU  - Tadashi Toki
AU  - Koichi Iwanaga
AU  - Koji Yonemoto
AU  - Mine Harada
AU  - Koichi Akashi
PY  - 2026
JO  - Cancer Science
DO  - 10.1111/cas.70485
UR  - https://doi.org/10.1111/cas.70485
ER  -

APA

Semba, Y., Miyamoto, T., Kasahara, S., Kikushige, Y., Maeda, T., Yoshimoto, G., Ota, S., Saito, A., Najima, Y., Hosoi, H., Niiya, D., Kato, K., Nagafuji, K., Akasaka, T., Kamimura, T., Takita, A., Narahara, M., Toki, T., Iwanaga, K., Yonemoto, K., Harada, M., & Akashi, K. (2026). Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory <scp>FLT3</scp> ‐ <scp>ITD</scp> –Positive <scp>AML</scp>. Cancer Science. https://doi.org/10.1111/cas.70485

Source records

crossref · retrieved 2026-09-25T08:23:19.382Z